1 option
Novo Nordisk's collapse : from market leader to underdog / Simran Mehta.
- Format:
- Book
- Author/Creator:
- Mehta, Simran, author.
- Series:
- SAGE business cases.
- SAGE business cases
- Language:
- English
- Subjects (All):
- Novo Nordisk--Cases studies.
- Novo Nordisk.
- Strategic planning--Cases studies.
- Strategic planning.
- Physical Description:
- 1 online resource : illustrations.
- Place of Publication:
- London : SAGE Publications: SAGE Business Cases Originals, 2025.
- Summary:
- Pharmaceutical giant Novo Nordisk gained global attention for surpassing Denmark's gross domestic product in 2024, recently the company has entered an atmosphere of uncertainty after its stocks plummeted in 2025. This case study dives deeper into the factors behind Novo Nordisk's underwhelming performance in the US markets, such as increased competition and the lack of regulations regarding compounded versions of its flagship products, Wegovy and Ozempic. Students will consider how the company can respond to these challenges to reposition itself at the forefront of the highly lucrative weight-loss drug market.
- Notes:
- Description based on XML content.
- ISBN:
- 979-83-488-4783-8
- OCLC:
- 1539039544
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.